About Informuta
Informuta is a company based in New Orleans (United States) founded in 2023 by Kalen Hall and Leo Williams. Informuta offers products and services including RESISENSE. Informuta operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
- Headquarter New Orleans, United States
- Founders Kalen Hall, Leo Williams
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Informuta, Inc.
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$13.35 M (USD)67.02as on Mar 31, 2023
-
Net Profit
$1.62 M (USD)27.55as on Mar 31, 2023
-
EBITDA
$2.28 M (USD)25.37as on Mar 31, 2023
-
Latest Funding Round
$275 K (USD), Grant
Sep 15, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Informuta
Informuta offers a comprehensive portfolio of products and services, including RESISENSE.
AI-based platform to predict drug resistance for better patient treatment
People of Informuta
Unlock access to complete
Unlock access to complete
Funding Insights of Informuta
Investors in Informuta
Informuta has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked |
Investor details for Informuta
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Informuta
Investment portfolio details for Informuta
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Informuta
Detailed financials for Informuta
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Informuta Comparisons
Peer comparison for Informuta
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Informuta
Informuta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Food safety technologies are provided for pathogen identification.
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Molecular diagnostics platform is provided for infectious disease detection.
|
Detailed competitors of Informuta
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Informuta
Complete news archive for Informuta
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Informuta
Informuta was founded in 2023 and raised its 1st funding round 1 year after it was founded.
Informuta is headquartered in New Orleans, United States. It is registered at New Orleans, Louisiana, United States.
Kalen Hall is the current CEO of Informuta. They have also founded this company.
Annual revenue of Informuta is $13.35M as on Mar 31, 2023.
Provider of predictive diagnostics for drug-resistant infections. It uses machine learning to analyze bacterial DNA to accurately guide effective treatment for difficult infections and predict if infections will become drug-resistant.
Informuta's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
Informuta offers RESISENSE.
Informuta has 1 investor. Key investors include National Science Foundation.